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The basolateral amygdala (BLA) plays crucial roles in stimulus value coding, as well as drug and alcohol
dependence. Ethanol alters synaptic transmission in the BLA, while endocannabinoids (eCBs) produce
presynaptic depression at BLA synapses. Recent studies suggest interactions between ethanol and eCBs
that have important consequences for alcohol drinking behavior. To determine how ethanol and eCBs
interact in the BLA, we examined the physiology and pharmacology of GABAergic synapses onto BLA
pyramidal neurons in neurons from young rats. Application of ethanol at concentrations relevant to
intoxication increased, in both young and adult animals, the frequency of spontaneous and miniature
GABAergic inhibitory postsynaptic currents, indicating a presynaptic site of ethanol action. Ethanol did
not potentiate sIPSCs during inhibition of adenylyl cyclase while still exerting its effect during inhibition
of protein kinase A. Activation of type 1 cannabinoid receptors (CB1) in the BLA inhibited GABAergic
transmission via an apparent presynaptic mechanism, and prevented ethanol potentiation. Surprisingly,
ethanol potentiation was also prevented by CB1 antagonists/inverse agonists. Brief depolarization of BLA
pyramidal neurons suppressed GABAergic transmission (depolarization-induced suppression of inhibi-
tion [DSI]), an effect previously shown to be mediated by postsynaptic eCB release and presynaptic CB1
activation. A CB1-mediated suppression of GABAergic transmission was also produced by combined
afferent stimulation at 0.1 Hz (LFS), and postsynaptic loading with the eCB arachidonoyl ethanolamide
(AEA). Both DSI and LFS-induced synaptic depression were prevented by ethanol. Our ﬁndings indicate
antagonistic interactions between ethanol and eCB/CB1 modulation at GABAergic BLA synapses that may
contribute to eCB roles in ethanol seeking and drinking.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The basolateral amygdala (BLA) plays key roles in value coding,
effect, and actions of abused drugs, including conditioned place
preference for ethanol and other substances (Brown & Fibiger,1993;
Davis, Rainnie, & Cassell, 1994; Everitt, Morris, O’Brien, & Robbins,
1991; Gremel & Cunningham, 2009; Hiroi & White, 1991; LeDoux,
1993, 2000; Olmstead & Franklin, 1997; Sarter & Markowitsch,
1985; See, Fuchs, Ledford, & McLaughlin, 2003; Stuber et al.,
2011). The BLA is also implicated in ethanol withdrawal-induced
increases in anxiety, as well as other withdrawal/abstinence-t of interest.
Neuroscience, National Insti-
Lane, Room TS-11, Bethesda,
80 8035.
ger).
access article under the CC BY-NCrelated behaviors (Läck, Christian, Diaz, & McCool, 2009; Läck,
Diaz, Chappell, DuBois, & McCool, 2007). Acute ethanol exposure
alters BLA neuron excitability and increases GABAergic synaptic
transmission onto BLA projecting neurons, including increasing
GABA release at synapses made by local interneurons (Silberman,
Ariwodola, & Weiner, 2009; Silberman, Shi, Brunso-Bechtold, &
Weiner, 2008; Zhu & Lovinger, 2006). GABAergic transmission at
interneuron synapses onto BLA projection neurons is also altered
after chronic ethanol exposure (Diaz, Christian, Anderson, &
McCool, 2011). It is important to elucidate ethanol actions in BLA
to gain a better understanding of the basis of cellular and circuit-
level effects of this drug.
Presynaptic, Gi/o-interacting G-protein-coupled receptors
(GPCRs) inhibit neurotransmitter release and prevent ethanol ef-
fects at GABAergic synapses in several brain regions (Ariwodola &
Weiner, 2004; Kang-Park, Kieffer, Roberts, Siggins, & Moore,
2007; Kelm, Criswell, & Breese, 2008; Offermanns, 2003; Roberto-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
G. Talani, D.M. Lovinger / Alcohol 49 (2015) 781e794782et al., 2010; Silberman et al., 2009; Theile, Morikawa, Gonzales, &
Morrisett, 2008; Wan, Berton, Madamba, Francesconi, & Siggins,
1996; Zhu & Lovinger, 2006), suggesting that endogenous neuro-
transmitter actions limit ethanol-induced increases in release. A
possible point of convergence for the ethanol and Gi/o-GPCRs is
adenylyl cyclase (AC). This cyclic AMP-generating enzyme can be
activated by ethanol (Tabakoff, Nelson, Yoshimura, Hellevuo, &
Hoffman, 2001) and inhibited by the GPCRs of interest. Deter-
mining which neurotransmitters produce these ethanol
potentiation-limiting effects at which synapses will help us to un-
derstand acute drug actions under different physiological
conditions.
Cannabinoid type 1 (CB1) receptors are predominantly presyn-
aptic and decrease neurotransmitter release (Freund, Katona, &
Piomelli, 2003; López-Moreno, González-Cuevas, Moreno, &
Navarro, 2008; Mackie, 2008; Matsuda, Bonner, & Lolait, 1993;
Wilson & Nicoll, 2001). CB1 expression is robust in the BLA, and
strongly localized to axon terminals of CCK-expressing GABAergic
interneurons (Katona et al., 2001). Endocannabinoids (eCBs),
endogenous lipid metabolites, activate CB1 receptors (Alger, 2009).
Arachidonoyl ethanolamide (AEA) and 2-arachidonoyl glycerol (2-
AG) are the best characterized eCBs (Heifets & Castillo, 2009). Re-
ceptor activation by eCBs usually involves “retrograde”
postsynaptic-to-presynaptic signaling that produces either short-
or long-term synaptic depression (Alger, 2009; Alger et al., 1996;
Heifets & Castillo, 2009; Lovinger, 2007, 2008; Ohno-Shosaku,
Maejima, & Kano, 2001; Wilson & Nicoll, 2001), both of which
have been observed at GABAergic synapses onto BLA principal
neurons (Marsicano et al., 2002; Patel, Kingsley, Mackie, Marnett, &
Winder, 2009; Szabo & Schlicker, 2005; Zhu & Lovinger, 2005). The
eCB-mediated reduction of GABA release enhances excitatory
output from BLA (Perra, Pillolla, Luchicchi, & Pistis, 2008).
Past studies have described interactions between eCB/CB1
signaling and acute ethanol effects, in which CB1 activation de-
presses GABAergic transmission and prevents ethanol potentiation
of GABA release (Kelm et al., 2008; Roberto et al., 2010). Signaling by
eCBs is also implicated in behavioral actions of ethanol, including
intake and preference, as well as conditioned place preference
(Alén et al., 2009; Arnone et al., 1997; Basavarajappa, Ninan, &
Arancio, 2008; Basavarajappa, Yalamanchili, Cravatt, Cooper, &
Hungund, 2006; Blednov, Cravatt, Boehm, Walker, & Harris, 2007;
Cippitelli et al., 2005, 2007; Colombo et al., 2007; Colombo, Serra,
Vacca, Carai, & Gessa, 2005; Economidou et al., 2006; Freedland,
Sharpe, Samson, & Porrino, 2001; Houchi et al., 2005; Hungund &
Basavarajappa, 2000, 2004; Manzanares, Ortiz, Oliva, Pérez-Rial, &
Palomo, 2005; Pava et al., 2012; Thanos, Dimitrakakis, Rice,
Gifford, & Volkow, 2005; Vinod, Sanguino, Yalamanchili,
Manzanares, & Hungund, 2008; Vinod, Yalamanchili, et al., 2008).
Chronic ethanol treatment produces tolerance to the behavioral
effects of cannabinoids (Pava et al., 2012). This evidence suggests
important eCB roles in regulation of the CNS effects of ethanol.
In the present study, we examine interactions between ethanol
and eCB/CB1 signaling at GABAergic synapses in rat BLA. In addi-
tion, studies have indicated that adolescent rats are less sensitive
than adults are to several ethanol actions in both electrophysio-
logical and behavioral experiments (Little, Kuhn, Wilson, &
Swartzwelder, 1996; Silveri & Spear, 1998; Van Skike et al., 2010).
Administration of low to moderate ethanol doses induces social
facilitation in young animals, while the same doses reduce social
behavior in adults (Varlinskaya & Spear, 2002). The different
response to ethanol in adolescents may play an important role in
the development of ethanol-related problems (Spear & Varlinskaya,
2005). For this reason, we evaluated, in a separate set of adult an-
imals, some of the effects observed in young rats regarding the
interaction between ethanol and the eCB system. Our ﬁndingsindicate a general antagonistic effect between ethanol and canna-
binoidergic transmission that has strong implications for acute
intoxication.
Materials and methods
Brain slice preparation
All experiments were approved by the NIAAA Animal Care and
Use Committee. Postnatal day 15e19 (young) or day 50e60 (adult)
Sprague Dawley rats were anesthetized by halothane inhalation.
After trans-cardial perfusion with ice-cold modiﬁed artiﬁcial cere-
brospinal ﬂuid (aCSF) containing (in mM): 194 sucrose, 30 NaCl, 4.5
KCl, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 glucose (pH 7.4 with
95% O2/5% CO2), they were then decapitated, and their brains
rapidly transferred into ice-cold modiﬁed aCSF. Coronal sections
(300 mm thickness) were cut in ice-cold modiﬁed aCSF using a Leica
VT1200S vibratome (Leica Microsystem Nussloch GmbH, Heidel-
berg, Germany). Slices were transferred immediately to a nylon net
submerged in normal aCSF containing (in mM): 124 NaCl, 4.5 KCl, 2
CaCl2, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 D-glucose, with
osmolarity set to 320 mOsm (pH 7.4), at 33 C for at least 30 min.
After an additional 1-h incubation at room temperature, hemi-
slices were transferred to a recording chamber, submerged in
normal aCSF with a constant ﬂow of w2 ml/min. For all experi-
ments, the temperature of the bath was maintained at w31 C
during any given experiment.
Neuronal isolation
Mechanical isolation of BLA neurons was performed as previ-
ously described (Jun, Cuzon Carlson, Ikeda, & Lovinger, 2011; Zhu &
Lovinger, 2005). Brieﬂy, coronal brain slices containing BLA were
transferred to a 35-mm diameter culture dish containing (in mM)
150 NaCl, 5 KCl, 10 HEPES, 1 MgCl2, 2.5 CaCl2, 10 D-glucose, pH
adjusted to 7.4 using NaOH, osmolarity set to w300 mOsm with
sucrose. Using a piezoelectric bimorph (Burleigh Instruments, NY),
the tip of a ﬂame-sealed micropipette was vibrated laterally at
30 Hz as it descended through the BLA. The slice was then removed
from the dish, leaving the isolated neurons.
Whole-cell voltage-clamp recording
In brain slices, whole-cell recordings were performed from BLA
principal neurons. Recording pipettes were pulled from borosilicate
glass on a Flaming Brown micropipette puller (Novato, CA). Pipette
resistance ranged from 2.5 to 4.5 MU, when ﬁlled with a CsCl-based
internal solution containing (in mM): 150 CsCl, 10 HEPES, 5 lido-
caine N-ethyl bromide (QX314), 2 MgCl2, 3 Mg-ATP, 0.3 Na-GTP, and
0.2 BAPTA-4K, pH adjusted to 7.2 with CsOH, and osmolarity set to
298 mOsm with sucrose. To exclude the presence of glutamatergic
synaptic responses, 50 mM AP5 and 5 mM NBQX were added to the
solution to block NMDA and AMPA receptor-mediated currents,
respectively. Cells were voltage-clamped at 60 mV. We analyzed
only recordings with series resistance values ranging from 9 to
25 MU without compensation, and if this value changed by more
than 20% during the course of an experiment, the cell was
discarded.
Synaptic currents were recorded with an Axopatch 700A
ampliﬁer (Axon Instruments, Foster City, CA), ﬁltered at 2 kHz, and
digitized at 5 kHz. Spontaneous IPSC amplitude and frequency were
measured using peak and event detection software in pCLAMP9.2
and analyzed by Minianalysis software (Synaptosoft, Decatur, GA,
USA). After initiation of the whole-cell recording, stable baseline
responses were observed within w10 min. After 2e3 additional
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protocol. For evoked IPSC recordings, the concentric bipolar stim-
ulating electrode was placed approximately 200 mm medial to the
recording site. This would certainly stimulate the inhibitory affer-
ents arising from local interneurons, but stimulation of afferents
from paracapsular cells cannot be ruled out. For DSI experiments,
after a recording period of approximately 3 min, the membrane
potential was stepped from 60 to 0 mV for 5 s under voltage
clamp. The magnitude of DSI was calculated as the sIPSC amplitude
and frequency after the depolarization divided by the average
during a 3-min pre-depolarization period. In a different set of ex-
periments, AEA (50 mM) was loaded in the patch electrode to in-
crease the pool of endocannabinoid available for release during DSI.
The low-frequency stimulation (LFS) protocol consisted of 0.1-Hz
stimulation for 3 min using a concentric bipolar electrode (FHC,
Bowdoin, ME). Stimulation intensity was set to induce an eIPSC
with an amplitude w50% of the maximal response.
In some experiments examining ethanol effects on DSI, the DSI
protocol was repeated three times in each neuron, once during the
baseline period, once in the presence of ethanol, and once after
washout. In other experiments the DSI protocol was run only once
per cell, and SR or ethanol were present throughout the recording.
In the experiments involving ethanol wash-on and washout, we
applied the DSI protocol after 3 min of stable baseline and
continued to record for an additional 3 min after DSI. We then
applied ethanol to the slice for a total of 5 min. Three minutes into
the ethanol application, if the response was stable, we applied the
DSI protocol again. Two minutes after this second DSI protocol, we
began the washout of ethanol. After a total of 4 min of washout, we
again applied the DSI protocol, and recorded for a further 3 min.
Whole-cell voltage-clamp recordings from isolated neurons were
performed on the stage of an inverted Nikon T200 microscope as
previously described (Zhu & Lovinger, 2006), using micropipettes
with resistances of 2e4 MU ﬁlled with the CsCl-based solution.
Solutions containing ethanol and other compounds were applied
via local perfusion using an array of fused square-tipped glass tubes,
with lateral movement driven by the Faststep steppermotor system
(Warner Instruments, Hamden, CT). Recordings were performed in
the presence of 5 mM NBQX and 25 mM AP5 to block fast gluta-
matergic transmission, allowing for measurement of spontaneous
GABAA receptor-mediated IPSCs.
Drugs
The following drugs were used: ethanol (Pharma corporation),
WIN 55,212, SR161417A, AEA, 2AG, H-89, BSE, and DDA (Sigma-
eAldrich, San Diego, CA), NBQX, D-AP5, TTX (Tocris, Ellisville, MO).
Statistical analysis
Statistical comparisons of pooled data were performed by t test,
or one-way ANOVA followed by the Tukey or Neuman-Keuls post
hoc tests, or repeated-measures two-way ANOVA. In all cases, a p
value of <0.05 was considered statistically signiﬁcant.
Results
Effect of ethanol on sIPSCs recorded from BLA principal neurons of
young rats
GABAergic sIPSCs occur with reliable frequency and amplitude
(Ampl. 56.3  6 pA; Freq. 8.4  0.8 Hz; n ¼ 73) in pyramidal
neurons examined in BLA brain slices (Fig. 1) from young rats, as
previously reported (Diaz, Chappell, Christian, Anderson, &
McCool, 2011; Diaz, Christian, et al., 2011; Silberman et al., 2008;Zhu & Lovinger, 2006). Consistent with previous studies
(Silberman et al., 2009; Zhu & Lovinger, 2006), application of
80 mM ethanol induced a signiﬁcant increase in sIPSC amplitude
and frequency that developed within 3e4 min of the onset of
ethanol application (Amp: 32  12% increase; Freq: 56  12% in-
crease; p < 0.05, paired t test), (Fig. 1AeC). The potentiation
reversed within 5 min after cessation of ethanol application.
Potentiation of sIPSC frequency by ethanol was concentration-
dependent (F[4,58] ¼ 3.89, p ¼ 0.007), without any signiﬁcant
concentration-dependence of the change in event amplitude,
where only the higher concentrations were signiﬁcant (p < 0.05,
paired t test) (Fig. 1D and E). In another set of neurons from young
rats, we examined action potential-independent miniature IPSCs
(mIPSCs) in the presence of the voltage-dependent sodium chan-
nel blocker TTX (1 mM) (basal amplitude 45.3  6.2 pA; basal
frequency 4  0.9 Hz; n ¼ 11). When ethanol (80 mM) was
perfused into the slice it increased mIPSC frequency by 41  18%
(p < 0.05, paired t test vs. control) without any signiﬁcant change
in amplitude (15  8.5%), (Fig. 1F and G).
Effect of adenylyl cyclase and PKA inhibitors on ethanol potentiation
of sIPSCs
Previous studies evaluated the adenylyl cyclase (AC) and protein
kinase A (PKA) effect on ethanol potentiation of GABA release (Kelm
et al., 2008; Roberto et al., 2010). Ethanol can activate AC (Luthin &
Tabakoff, 1984; Rabin & Molinoff, 1981), and we thus examined
effects of AC activation and inhibition, as well as PKA inhibition, on
GABAergic sIPSCs and ethanol potentiation in BLA slices fromyoung
animals. As previously described in hippocampus (Chevaleyre,
Heifets, Kaeser, Südhof, & Castillo, 2007) and prefrontal cortex
(Chiu, Puente, Grandes, & Castillo, 2010), a 30-min pre-incubation
with the 10 mM AC inhibitor dideoxy-adenosine (DDA) or the PKA
inhibitor H-89 (10 mM) decreased basal sIPSC frequency without
affecting amplitude (Fig. 2AeC). Bath application of the AC activator
forskolin (10 mM) potentiated sIPSC frequency. The forskolin effect
was prevented by previous incubation of slices in 10 mM DDA
(Fig. 2D and E). The increases in sIPSC amplitude and frequency
induced by 80 mM ethanol were reduced in slices incubated with
DDA (Fig. 2F), as previously reported (Kelm et al., 2008). However,
in slices treated with H-89, ethanol was still able to induce an in-
crease in sIPSC frequency that was not distinguishable from the
effect of ethanol alone (Fig. 2F). A signiﬁcant difference among the
three treatment groups in ethanol effects on sIPSC amplitude was
observed (one-way ANOVA, F[2,14] ¼ 8.28, p ¼ 0.0042), with post
hoc Tukey multiple comparisons indicating signiﬁcant differences
only between the ethanol alone and DDA þ ethanol treatments.
Analysis of the sIPSC frequency data indicated a signiﬁcant effect of
treatment (F[2,14] ¼ 7.004, p ¼ 0.0078), with post hoc comparisons
indicating signiﬁcant differences only between the ethanol alone
versus DDA þ ethanol group. One-sample t tests indicated that
ethanol produced signiﬁcant increases in sIPSC frequency in all
groups, and thus DDA did not completely eliminate ethanol
potentiation of GABAergic transmission.
CB1R interactions with ethanol-induced increases in GABA release
We next determined whether CB1 receptor activation alters
synaptic transmission and ethanol potentiation at GABAergic ter-
minals in BLA principal neurons recorded from brain slices made
from young animals, as has been observed at other synapses
(Roberto et al., 2010). The CB1 agonist WIN 55,212 (WIN) (5 mM)
signiﬁcantly decreased sIPSC frequency (35.7  7% below baseline,
p < 0.01), but not amplitude (6.7  4.4) (Fig. 3A and B). Once sIPSC
frequency had reached a stable level in the presence of WIN, we
Fig. 1. Ethanol increases GABAergic transmission onto BLA principal neurons. A and B) Graphs showing the effect of 5-min 80 mM ethanol perfusion on both sIPSC amplitude (A) and
frequency (B). C) Representative current traces obtained from a single neuron before, during, and 5 min after ethanol perfusion (scale bar 100 pA, 10 s). D and E) Bar graph showing
the average ethanol effect on sIPSCs at different concentrations (10, 25, 50, 80, and 150 mM). The extent of the ethanol effect was calculated during the 2 min in which the drug
showed its maximal effect. Data are expressed as mean  SEM (n ¼ 5, 9, 11, 27, and 11 cells, respectively). F) Bar graph showing 80-mM ethanol effects on amplitude and frequency of
TTX-insensitive sIPSCs (mIPSCs) (n ¼ 11 cells) (*p< 0.05 vs. baseline, paired t test). G) Representative traces of mIPSCs recorded from a single neuron before, during, and after ethanol
slice perfusion (scale bar 50 pA, 5 s).
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No signiﬁcant change in sIPSC frequency or amplitude was
observed during ethanol (80 and even 150 mM) application in the
presence of WIN (Fig. 3C and D) (p > 0.05, t test vs. baseline).We next evaluated the effect of ethanol in the presence of the
CB1 antagonist/inverse agonist SR141716A (SR) (1 mM) in the slice
preparation. The compound was applied for 3 min prior to 5-min
co-application of ethanol (80 mM), and SR did not alter sIPSC
Fig. 2. Roles of adenylyl cyclase and protein kinase A in ethanol potentiation of sIPSCs. A and B) Bar graphs showing the effect of 30-min incubation of slices with the PKA inhibitor
H-89 (10 mM) or the AC inhibitor DDA (10 mM). Neither compound altered sIPSC amplitude (A), but both produced a decrease in sIPSC frequency (B) (n ¼ 54, 11, 21) (*p< 0.05 vs. aCSF
unpaired t test. C) Representative traces obtained from different neurons incubated in normal aCSF, or after 30 min of H-89 or DDA incubation. Scale bar ¼ 50 pA, 10 s. D and E)
Forskolin (20 mM) increased sIPSC frequency, and this effect was dramatically decreased in slices incubated for 30 min with DDA. Representative current traces in D show forskolin
effects on sIPSCs in the absence (top) and presence (bottom) of DDA. Scale bar ¼ 50 pA, 10 s. Bar graphs in E show the forskolin and forskolin þ DDA effects on sIPSC amplitude and
frequency (n ¼ 5, 3) (*p < 0.05 vs. baseline paired t test; #p < 0.05 vs. forskolin, unpaired t test). F) The AC inhibitor DDA decreases ethanol potentiation of the amplitude and
frequency of sIPSCs recorded from BLA-projecting neurons, while the PKA inhibitor H-89 did not signiﬁcantly alter ethanol actions (n ¼ 27, 7, 5) (*p < 0.05 vs. baseline, paired t test).
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ethanol (Fig. 3EeG) (p < 0.05 vs. baseline, t test). The increase in
sIPSC frequency induced by 80 mM ethanol was intact in the
presence of DMSO (dimethyl sulfoxide, 0.01%), the carrier used to
dilute SR (Amp: 27.6  4.8%, Freq: 56.9  6.5% increase; data not
shown). Another CB1 antagonist/inverse agonist, AM251 (1 mM)
also prevented ethanol (80 mM) potentiation of sIPSC frequency
and amplitude (amp ¼ 0.57  1.3%, paired t test, p > 0.05,
freq ¼ 2.3  4.6%, paired t test, p > 0.05, n ¼ 11). However, when a
high concentration of ethanol (150 mM) was used, SR did not
reduce ethanol potentiation of sIPSC frequency (paired t test,
p < 0.05, t ¼ 3.58, df ¼ 6; unpaired t test ethanol þ vehicle vs.
ethanol þ SR, p ¼ 0.92, t ¼ 0.098, df ¼ 19) (Fig. 3H).
In mechanically isolated BLA principal neurons from young an-
imals, we observed sIPSCs, and application of 80-mM ethanol
increased sIPSC amplitude and frequency (Fig. 4A, C, D) (p< 0.05 vs.baseline, t test), consistent with our previous observations (Zhu &
Lovinger, 2005). In a separate set of neurons we applied SR
(1 mM) throughout the recording. Similar to what was observed by
Zhu and Lovinger (2005), SR perfusion induced an increase in sIPSC
frequency of 52  20% above baseline in 58% (4 of 7) of cells tested.
However, no potentiation was observed in the remaining cells. In
the presence of SR, ethanol 80 mM failed to increase the frequency
and amplitude of sIPSCs (Fig. 4BeD). Thus, the ability of the CB1
antagonist/inverse agonist to prevent potentiation by ethanol is not
dependent on intact circuitry or the slice milieu, and is likely due to
a more direct effect on ethanol-sensitive axon terminals.
Ethanol reduces DSI at synapses on BLA principal neurons
To determine if ethanol alters eCB actions at BLA GABAergic
synapses, we ﬁrst examined depolarization-induced suppression of
Fig. 3. CB1 agonists and antagonists modulate ethanol effects on sIPSCs. A and B) sIPSC amplitude (A) and frequency (B) plotted as a function of time during an experiment in which
the CB1 agonist WIN 55,212 (5 mM) was applied to BLA slices prior to application of 80 mM ethanol. The agonist reduced sIPSC frequency and abolished potentiation by ethanol. C, D)
Bar graphs showing the average ethanol effect on sIPSC amplitude and frequency at two different concentrations (80 mM, C; and 150 mM, D) in the presence and absence of WIN.
Data were collected from 5 to 11 cells (*p < 0.05 vs. baseline, paired t test). E, F) Graphs showing the time course of 80 mM ethanol effects on sIPSC amplitude and frequency,
respectively, in the presence and absence of the CB1 antagonist SR (1 mM). G and H) Bar graph showing the average ethanol effect at two different concentrations (80 and 150 mM) in
the presence and absence of the CB1 antagonist/inverse agonist. Data were collected from 8 to 12 cells (*p < 0.05 vs. baseline, paired t test).
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Fig. 4. Ethanol potentiation is prevented by a CB1 antagonist/inverse agonist in
vibrodissociated BLA projection neurons. A and B) Representative traces obtained from
single neurons before and during ethanol application using fast perfusion in the
absence and presence of the CB1 antagonist SR (1 mM) (scale bar 200 pA, 60 s). C) Time
course of the effect of 80 mM ethanol on sIPSC frequency in the presence and absence
of the CB1 antagonist SR (n ¼ 12 cells). D) Bar graph showing the average ethanol effect
on sIPSC amplitude and frequency in the presence and absence of the CB1 antagonist/
inverse agonist (*p < 0.05 vs. baseline, paired t test).
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pyramidal neuron from 60 to 0 mV for 5 s induced a fast-onset,
transient (15e20 s post-depolarization duration) decrease in
sIPSC frequency (25.7  2.7% below baseline, p < 0.01 paired t test,
n ¼ 45) (Fig. 5A and B), as observed in previous studies (Patel et al.,
2009; Zhu & Lovinger, 2006). Application of 50 or 80 mM ethanol
for 3 min increased sIPSC frequency as previously observed (%
increase ¼ 28  5.1 at 50 mM, 33  13.6 at 80 mM), while 25 mMethanol had no effect. In the pre-ethanol baseline condition, post-
synaptic depolarization produced signiﬁcant sIPSC frequency
depression (Fig. 5B and C) (p < 0.05 vs. baseline, t test). As shown in
Fig. 5B and C, application of different concentrations of ethanol
reduced the depolarization-induced decrease in sIPSC frequency
(repeated-measures two-way ANOVA, signiﬁcant treatment effect F
[1,30] ¼ 23.1, p < 0.05), with no signiﬁcant effect of ethanol con-
centration or signiﬁcant interaction. No signiﬁcant decrease in
sIPSC frequency was observed following depolarization in the
presence of the 50 or 80 mM concentrations (Fig. 5C). This decrease
in DSI was reversed when ethanol was removed from the prepa-
ration (Fig. 5C), indicating that the loss of sIPSC depression was not
due to a time-dependent loss of DSI. The depolarization protocol
did not alter sIPSC amplitude in the absence or presence of ethanol
(Fig. 5D) (p > 0.05, two-way ANOVA).
To try to enhance DSI magnitude, and perhaps bypass ethanol
effects on eCB synthesis, we ﬁlled the patch electrode with AEA
(10 mM) or 2-AG (10 mM) and applied the depolarization protocol in
these eCB-loaded cells. The magnitude and time course of DSI were
unchanged in neurons ﬁlled with AEA relative to neurons ﬁlled
with the standard internal solution containing CsCl (Fig. 5B, E, F).
We obtained the same result ﬁlling the recording electrode with 2-
AG (decrease in sIPSC freq. following DSI ¼ 36.8  6.6 below
baseline). Bath application of the CB1 antagonist/inverse agonist SR
(1 mM) prevented DSI in AEA-loaded cells (Fig. 5E and F). Bath
application of 80 mM ethanol prevented DSI in the AEA-loaded
cells, as observed in the non-loaded neurons (Fig. 5E and F), (F
[3,45] ¼ 11.43, p < 0.05). This ﬁnding suggests that the effects of
ethanol are not via inhibition of eCB synthesis.
Effect of ethanol and CB1 agonist in adult rats
The effects of ethanol and CB1 agonists on GABAergic synapses
might be dependent on the developmental stage of animals tested,
as previous studies have indicated such changes over development
in other brain regions and in behavioral tests (Little et al., 1996;
Silveri & Spear, 1998; Van Skike et al., 2010). As observed in
young rats, GABAergic sIPSCs occur with reliable frequency and
amplitude in BLA principal neurons from adults (Ampl.
38.86 3.14 pA; Freq. 3.310.38 Hz; n¼ 26). Application of 80mM
ethanol induced a signiﬁcant increase in sIPSC amplitude and fre-
quency recorded in BLA slices from adult animals, similar to what
was observed in young rats (Amp: 27.8  3.38% increase; Freq:
37.8  9.6% increase; p < 0.05 one-sample t test vs. baseline)
(Fig. 6AeD). As previously observed, the potentiation reversed
within 5 min after cessation of ethanol application. To evaluate the
interaction between ethanol and eCB, we ﬁrst examined ethanol
actions in the presence of the CB1 agonist. As observed in young
rats, WIN 55,212 (5 mM) decreased sIPSC frequency (65.4  6.2%
below baseline, p < 0.001) (Fig. 7A) without any change in sIPSC
amplitude (data not shown). After sIPSC frequency had reached a
stable level in the presence of WIN, we applied 80-mM ethanol in
the continued presence of CB1 agonist. Even in adult animals, no
signiﬁcant change in sIPSC frequency was observed during ethanol
application in the presence of WIN (Fig. 7A and B) (p < 0.05 vs.
baseline, t test). To determine whether ethanol alters eCB actions at
GABAergic synapses in neurons from adult animals, we used the DSI
protocol. DSI induced a decrease in sIPSC frequency (40.61  6.42%
below baseline, p< 0.01 paired t test, n¼ 4) (Fig. 7C) during the ﬁrst
15 s after cessation of the depolarization step. Application of 80-
mM ethanol signiﬁcantly reduced the magnitude of the decrease
in sIPSC frequency induced by the DSI protocol, and the effect of DSI
recovered completely after a 5e10-min ethanol washout (Fig. 7C
and D) (p< 0.05 vs. baseline, t test), indicating that the loss of sIPSC
depression was not due to a time-dependent loss of DSI.
Fig. 5. Depolarization-induced suppression of inhibition in BLA is prevented by ethanol. A) Representative traces showing that a depolarizing step from 60 mV to 0 mV, applied for
5 s to a single BLA pyramidal neuron, produced a rapid, short-lasting decrease in sIPSC frequency vs. the baseline-recording period, without any signiﬁcant modiﬁcation in amplitude
(scale bar 50 pA, 5 s). B) Graph showing normalized sIPSC frequency over time before, during, and after depolarization using our standard CsCl-containing intracellular solution
(open circles) and in the presence of 80 mM ethanol (closed circles) (n ¼ 28, 11). C and D) Bar graphs show the average normalized sIPSC frequency (C) and amplitude (D) measured
over the ﬁrst 15 s after depolarization in control conditions (ACSF only), in the presence of different concentrations of ethanol (25, 50, 80 mM), and after 5 min of ethanol washout
(n ¼ 11 for all groups) (*p < 0.05 vs. baseline, paired t test). E) Time course of normalized sIPSC frequency before, during, and after depolarization in recordings made from BLA
projection neurons after loading the patch electrode with AEA (10 mM). Recordings were made either in standard aCSF (white circles), aCSF containing SR141716A (1 mM) (gray
circles), or aCSF containing 80 mM ethanol (black triangles). (n ¼ 12, 6, 3 cells). F) Summary graph showing DSI magnitude in all CsCl-ﬁlled, AEA-ﬁlled, AEA þ SR and AEA þ ethanol
cells (n ¼ 28, 12, 6, 3 cells) (*p < 0.05 vs. baseline, paired t test).
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Fig. 6. Ethanol increases GABAergic transmission onto BLA principal neurons in adult rats (PND 50e60). A and B) Time course plots showing the effect of 5-min 80 mM ethanol
perfusion on both sIPSC amplitude (A) and frequency (B). C) Representative current traces obtained from a single neuron before, during, and 5 min after ethanol perfusion (scale bar
100 pA, 10 s). D) Bar graph showing the average effect of 80 mM ethanol on sIPSCs amplitude and frequency. The extent of the ethanol effect was calculated during the 2 min in
which the drug showed its maximal effect. Data are expressed as mean  SEM (n ¼ 8 cells), (*p < 0.05 vs. baseline, paired t test).
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by low-frequency afferent activation
We combined afferent stimulation with postsynaptic loading of
AEA in neurons from young animals, in the presence of NBQX
(5 mM) and APV (50 mM), to determine whether we could produce
CB1-dependent synaptic depression while bypassing mechanisms
involved in eCB production. Afferent stimulation at 0.1 Hz (LFS) for
3 min induced a signiﬁcant decrease in sIPSC frequency that per-
sisted for over 3 min following cessation of stimulation in re-
cordings from AEA-ﬁlled BLA pyramidal neurons (Fig. 8A and B). In
cells ﬁlled only with the CsCl-based pipette solution, LFS did not
alter sIPSC frequency (Fig. 8A and B). The decrease in sIPSC fre-
quency observed with LFS plus AEA loading (10 mM) was prevented
by SR (Fig. 8C and D), consistent with previous observations in
striatum that combined synaptic activation and postsynaptic eCB
loading induce CB1-dependent synaptic depression (Adermark &
Lovinger, 2009; Ronesi & Lovinger, 2005). LFS failed to alter sIPSC
frequency in AEA-loaded neurons in the presence of 80mM ethanol
(Fig. 8E and F). One-way ANOVA indicated signiﬁcant differences
across conditions (F[3,140] ¼ 26.6, p < 0.05), and post hoc analyses
with the Neuman-Keuls Multiple Comparison Test revealed signif-
icant differences (p < 0.05) in the AEA vs. CsCl alone-loaded com-
parison, the AEA vs. AEA þ SR comparison, and the AEA vs.
AEA þ ethanol comparison, but not in other comparisons. These
ﬁndings indicate that ethanol inhibits eCB-mediated synaptic
depression and likely does so at a step that occurs after eCB syn-
thesis, as the depression we observed only occurred at synapses
onto eCB-loaded neurons.Discussion
The present study indicates that ethanol interacts with the BLA
eCB/CB1 signaling system in several ways. Strong activation of the
CB1 receptor prevents ethanol potentiation of GABA release,
consistent with previous studies (Perra et al., 2008; Roberto et al.,
2010), and consistent with other studies indicating that several
Gi/o-coupled GPCRs prevent presynaptic ethanol actions in BLA and
elsewhere (Ariwodola &Weiner, 2004; Kang-Park et al., 2007; Kelm
et al., 2008; Roberto et al., 2010; Silberman et al., 2009; Wan et al.,
1996; Zhu & Lovinger, 2006). Importantly, we observed that ethanol
interactions with eCB/CB1 signaling are not only conﬁned to young
animals but are also present in the adult. Thus, developmental
changes in ethanol sensitivity that have been noted in other brain
regions and in behavioral tests (Little et al., 1996; Silveri & Spear,
1998; Van Skike et al., 2010) do not appear to be occurring at BLA
GABAergic synapses. The opposing ethanol and GPCR actions may
involve AC, as ethanol is known to potentiate the function of certain
ACs (Rabin & Molinoff, 1981; Tabakoff et al., 2001), while Gi/oa
subunits liberated by receptor activation are AC inhibitors (Davis,
Ronesi, & Lovinger, 2003; Freund et al., 2003; Wartmann,
Campbell, Subramanian, Burstein, & Davis, 1995). Our ﬁndings
indicate that AC inhibition interferes with ethanol potentiation of
GABA release, supporting a role for this signaling system in ethanol
actions. Interestingly, PKA inhibition did not appear to alter ethanol
actions as effectively as did AC inhibition. This might indicate a role
for increased cAMP independent of PKA activation. It is not yet
known how these signaling pathways are recruited in vivo, and how
they may alter ethanol-related behaviors. The ability of CB1
Fig. 7. CB1 agonists modulate ethanol effects on sIPSCs in BLA slices from adult rats. A) sIPSC frequency plotted as a function of time during an experiment in which the CB1 agonist
WIN 55,212 (5 mM) was applied to BLA slices prior to application of 80 mM ethanol. The agonist reduced sIPSC frequency and abolished potentiation by ethanol. B) Bar graph
showing the effect of ethanol alone as well as ethanol þ WIN in the modulation of sIPSC frequency (*p < 0.05 vs. baseline, paired t test). C) Graph showing normalized sIPSC
frequency over time before, during, and after depolarization using our standard CsCl (open circles), in the presence of 80 mM ethanol (closed squares) and after ethanol washout
(open triangles). D) Bar graphs show the DSI effect on sIPSC frequency during the ﬁrst 15 s after DSI, using our standard CsCl, in the presence of ethanol and after ethanol washout
(*p < 0.05 vs. baseline, paired t test).
G. Talani, D.M. Lovinger / Alcohol 49 (2015) 781e794790agonists to prevent ethanol potentiation of GABAergic transmission
has implications for the effect of combined ethanol and synthetic or
phytocannabinoid use. The cannabinoid drugs appear to be able to
suppress this ethanol action, adding another layer of complexity to
the interactions of these often co-abused substances that must be
kept in mind when examining interactions in vivo.
Surprisingly, CB1 antagonists/inverse agonists also reduced
ethanol potentiation in both brain slices and isolated neurons. It is
odd that both agonists and antagonists/inverse agonists have the
same action. Perhaps CB1 receptors are constantly activated by
tonic eCB signaling that would produce a tone of AC inhibition. The
antagonist/inverse agonist could relieve this tone, and might then
occlude ethanol potentiation. This scenario seems unlikely, given
that no increase in sIPSC frequency, indicative of relief of the tone,
was observed during CB1 antagonist/inverse agonist application in
BLA slices. Another possibility is that ethanol potentiation involves,
at least in part, actions on the CB1 receptor or proximal signaling
molecules such as the G protein itself. In this case, strong receptor
activation would counteract ethanol actions while receptor occu-
pancy with an inverse agonist might also render the receptor or G
protein insensitive to other modulators. The SR prevention of
ethanol actions in the neuron/synaptic bouton preparation sup-
ports the idea that the site of interaction is located at the synaptic
terminal itself. A high ethanol concentration was effective in
potentiating GABA release in the presence of SR, indicating that theantagonist/inverse agonist effect can be overcome if the alcohol
effect is sufﬁciently strong. This ﬁnding may provide a clue as to
how prevention of ethanol effects differs when CB1 is occupied by
different ligands. Our ﬁndings are similar to the observation in
hippocampus by Basavarajappa et al. (2008), who showed antago-
nism between SR and ethanol effects on glutamate release as well
as in BLA by Perra et al. (2008), but differ from those in previous
studies that examined effects of GPCR blockade on ethanol poten-
tiation of GABA release (Silberman et al., 2009), including a study in
which CB1 antagonist/inverse agonist treatment did not interfere
with ethanol potentiation in central amygdala (Roberto et al., 2010).
It is likely that the interactions between ethanol and eCB/CB1
signaling are more complex in BLA than in other brain regions, as
our ﬁndings with DSI- and LFS-induced synaptic depression (dis-
cussed below) suggest.
While the observation that ethanol interacts with CB1 receptor
function is not new when considering ﬁndings from other brain
regions, acute ethanol interactions with synaptic signaling by
endocannabinoids has not been explored. This set of experiments is
crucial for understanding the full range of effects that ethanol will
have on this neuromodulatory system in the intact nervous system.
Thus, we examined ethanol effects on DSI, and observed a revers-
ible prevention of the decrease in GABA release normally induced
by postsynaptic depolarization in the DSI protocol. This action may
actually override any effects of CB1 activation on ethanol
Fig. 8. Ethanol antagonized the decreased sIPSC frequency induced by low-frequency afferent stimulation (LFS) in BLA slices. A and B) Low frequency electrical afferent stimulation
(0.1 Hz) in BLA induced a decrease in sIPSC frequency only when the patch electrode was loaded with the standard CsCl-based intracellular solution plus the eCB AEA (AEA loaded),
but not in the absence of the eCB (CsCl) (n ¼ 3, 9). C and D) The decrease in sIPSC frequency induced by LFS in AEA-loaded neurons is antagonized by SR 1 mM bath application
throughout the experiment (n ¼ 7). E and F) The decrease in sIPSC frequency induced by LFS in AEA-loaded neurons is also prevented by bath application of 80 mM ethanol (n ¼ 5)
(all scale bars 50 pA, 5 s).
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observed with exogenous agonist application as in Figs. 3, 4 and 7).
It appears that, in the presence of ethanol, the endocannabinoid is
either not released or cannot activate CB1 receptors, and this action
would have the net effect of maintaining strong GABAergic trans-
mission under conditions when it would normally be suppressed.
The combined potentiation of GABAergic transmission and DSI
suppression by ethanol has the potential to suppress BLA output
quite strongly. There are several mechanisms through which
ethanol might alter endocannabinoid modulation of GABA release,
and we explored some of these possibilities with additional ex-
periments. Ethanol prevented DSI even when the postsynaptic
neuron was loaded with AEA during the experiment, suggesting
that increasing the eCB available for release could not overcome the
ethanol effect. It must be noted, however, that postsynaptic AEA
loading did not alter DSI magnitude, and thus we cannot be conﬁ-
dent that this treatment enhances eCB signaling under thisexperimental condition. Application of LFS to activate transmission
onto AEA-loaded BLA neurons induced depression of sIPSC fre-
quency. This synaptic depression resembles effects of post-
synaptically loaded eCBs previously observed in striatum and
hypothalamus (Adermark & Lovinger, 2009; Gerdeman, Ronesi, &
Lovinger, 2002; Jo, Chen, Chua, Talmage, & Role, 2005; Ronesi &
Lovinger, 2005). As observed with DSI, ethanol prevented the LFS/
loading-induced synaptic depression. The ability of ethanol to
prevent eCB/CB1-mediated synaptic plasticity at GABAergic BLA
synapses is likely due to interference with eCB release or presyn-
aptic signaling. It seems unlikely that interference with eCB syn-
thesis accounts for these actions, as there is ample AEA available in
the LFS/AEA-loading experiment. Given the ethanol potentiation of
GABA release, the interference with eCB-retrograde signaling by
this drugmight be due to increased probability of GABA release that
counteracts the ability of CB1 to inhibit this process in both young
and adult rats. However, the experiments examining CB1 agonist
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simple, as agonist-induced synaptic depression is clearly intact
during ethanol exposure (Fig. 3B).
Ethanol blockade of eCB retrograde signaling and antagonist/
inverse agonist prevention of ethanol potentiation may be related.
Ethanol may interfere with CB1/G protein signaling when receptors
are occupied by a partial agonist like AEA, but this effect might be
reduced in the presence of an antagonist/inverse agonist and
eliminated altogether when a full agonist acts on the receptor.
Regardless of the molecular mechanisms involved, our ﬁndings
indicate complex antagonistic interactions between ethanol and
eCB/CB1 signaling that may differ when ethanol is the only drug
ingested or when a CB1 agonist is also present.
Consistent with previous studies, we observed that ethanol in-
creases GABAergic synaptic transmission via apparent presynaptic
mechanisms in brain slices and the “neuron/synaptic bouton”
preparation from BLA, supporting the idea that ethanol actions take
place at the axon terminal itself (Lovinger & Roberto, 2013; Roberto,
Madamba, Moore, Tallent, & Siggins, 2003; Silberman et al., 2009;
Zhu & Lovinger, 2006). It is tempting to speculate that this may
occur mainly at synapses made by local, as opposed to intercalated,
BLA interneurons, given the ﬁnding that presynaptic ethanol
potentiation mainly occurs at local-circuit synapses (Silberman
et al., 2009). It is known that CB1 receptors are expressed by CCK-
positive local interneurons in the basal and lateral amygdala,
most likely on synaptic terminals (Katona et al., 2001). This study
and physiological evidence from Geracitano, Kaufmann, Szabo,
Ferraguti, and Capogna (2007) indicate that CB1 receptors are not
present or functional on paracapsular synapses onto BLA principal
neurons. These ﬁndings support the idea that the ethanol-eCB/CB1
interactions we have observed mainly involve local interneuron
synapses. However, we did not directly evaluate the cellular origin
of the affected synapses in this study. Similar acute ethanol effects
have now been observed repeatedly at GABAergic synapses inmany
brain regions (Kelm, Criswell, & Breese, 2011; Roberto et al., 2010;
Zhu & Lovinger, 2006). Thus, the presynaptic effects of ethanol
appear to strongly contribute to the pro-GABAergic effects observed
in vivo (Criswell & Breese, 2005; Perra et al., 2008).
The potentiation of GABA release by forskolin, and the reduction
in ethanol potentiation by an AC inhibitor, also ﬁt with a growing
literature implicating this signaling molecule in presynaptic
ethanol actions at GABAergic synapses (Das, Pany, Rahman, & Slater,
2009; Kelm et al., 2008; Yoshimura, Pearson, Kadota, & Gonzalez,
2006). Pharmacological and gene knockout data indicate that
intact AC/PKA signaling is necessary for acute ethanol-induced in-
creases in GABA release (Kelm et al., 2008; Roberto et al., 2010). This
may be related to the ability of ethanol to stimulate some AC sub-
types (Luthin & Tabakoff, 1984; Rabin & Molinoff, 1981; Tabakoff
et al., 2001). It will be important to determine the pattern of AC
subtype expression at ethanol-sensitive GABAergic synapses.
Considerable evidence suggests involvement of the eCB/CB1
signaling system in the pharmacological (Perra et al., 2008; Roberto
et al., 2010) and behavioral actions of ethanol, including reward,
preference, and self-administration (Arnone et al., 1997; Colombo
et al., 2005, 2007; Hungund & Basavarajappa, 2004; Manzanares
et al., 2005; Thanos et al., 2005). The speciﬁc role in alcohol-
related behaviors of eCBs and CB1 in the BLA has not been inves-
tigated. However, the BLA has important roles in value coding, and
evidence indicates important roles for BLA GABAergic transmission
in control of anxiety (Bueno, Zangrossi, & Viana, 2005; Diaz,
Chappell, et al., 2011; Gonzalez, Andrews, & File, 1996; Pesold &
Treit, 1995; Sanders & Shekhar, 1995; Silberman, Ariwodola,
Chappell, Yorgason, & Weiner, 2010). Acute ethanol intoxication is
generally associated with decreased anxiety, while withdrawal af-
ter chronic exposure can be anxiogenic (Heilig, Egli, Crabbe, &Becker, 2010; Kliethermes, 2005). Treatments that reduce activa-
tion of BLA projection neurons reduce withdrawal-induced in-
creases in anxiety (Läck et al., 2007, 2009). Furthermore, CB1
receptors regulate affective behavior and responses to stressful
stimuli via mechanisms involving the BLA (Brzózka, Fischer, Falkai,
& Havemann-Reinecke, 2011; Martin, Ledent, Parmentier, Maldo-
nado, & Valverde, 2002), and these neural actions are likely to be
altered by ethanol. Altering inhibitory input to BLA projection
neurons will inﬂuence output from this important nucleus, and
thus it will be interesting to see whether manipulation of BLA
GABAergic inhibition by eCBs or CB1 alters withdrawal-induced
anxiety.
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